Is medical MDMA about to become legal? FDA’s upcoming decision could change psychedelic medicine
To move the drugs forward, manufacturers may need to follow the agency’s advice for elevating the quality of evidence.
Joshua Cohen is an independent health care analyst and freelance writer based in Boston, and the author of Undark's Cross Sections column.
To move the drugs forward, manufacturers may need to follow the agency’s advice for elevating the quality of evidence.